Skip to main content
Equibles
SNDX $17.60 -3.40%
SNDX logo
SNDX · Syndax Pharmaceuticals Inc
Track SNDX — free

Use SNDX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SNDX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$17.60 -0.62 (-3.40%) At close · Oct 2
Russell 2000 member Rebalance outlook locked
Market Cap
$1.63B
Shares
89.30M
Volume · Oct 2 2.56M Avg daily vol (3M) 1.6M
All webcasts

Earnings call · FY2026 Q1

Syndax Pharmaceuticals Inc (SNDX) Q1 2026 Earnings Call

Concluded Apr 30, 2026
Apr 30, 2026 0 turns
Period
FY2026 Q1
Runtime
—
Sources
2 artifacts
8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue $64.86M +223.6% YoY
Diluted EPS -$0.48
Net income -$42.67M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Apr 30, 2026 10-Q report Filed Apr 30, 2026 Company webcastOpen the original investor-relations page

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Product$48.92M +144.1% YoY
Collaboration Revenue$15.94M
Full-screen source Call document

SNDX transcript alerts

Syndax Pharmaceuticals Inc

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →